Klingenstein Fields & Co’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-195,210
| Closed | -$17M | – | 187 |
|
|
2024
Q1 | $17M | Sell |
195,210
-3,398
| -2% | -$290K | 0.71% | 53 |
|
|
2023
Q4 | $16.4M | Sell |
198,608
-1,665
| -0.8% | -$127K | 0.73% | 53 |
|
|
2023
Q3 | $15.7M | Buy |
200,273
+624
| +0.3% | +$52.2K | 0.77% | 49 |
|
|
2023
Q2 | $17.6M | Sell |
199,649
-1,809
| -0.9% | -$156K | 0.81% | 49 |
|
|
2023
Q1 | $16.2M | Sell |
201,458
-1,889
| -0.9% | -$154K | 0.81% | 50 |
|
|
2022
Q4 | $15.8M | Sell |
203,347
-1,454
| -0.7% | -$118K | 0.82% | 50 |
|
|
2022
Q3 | $16.5M | Sell |
204,801
-567
| -0.3% | -$51K | 0.91% | 47 |
|
|
2022
Q2 | $18.4M | Sell |
205,368
-383
| -0.2% | -$38.8K | 0.96% | 41 |
|
|
2022
Q1 | $22.8M | Buy |
205,751
+1,009
| +0.5% | +$107K | 0.98% | 40 |
|
|
2021
Q4 | $21.2M | Sell |
204,742
-3,368
| -2% | -$390K | 0.85% | 49 |
|
|
2021
Q3 | $26.1M | Sell |
208,110
-8,100
| -4% | -$1.05M | 1.11% | 32 |
|
|
2021
Q2 | $26.8M | Buy |
216,210
+7
| +0% | +$879 | 1.11% | 33 |
|
|
2021
Q1 | $25.5M | Sell |
216,203
-8,521
| -4% | -$999K | 1.15% | 30 |
|
|
2020
Q4 | $26.3M | Sell |
224,724
-699
| -0.3% | -$77K | 1.19% | 31 |
|
|
2020
Q3 | $23.4M | Sell |
225,423
-2,550
| -1% | -$256K | 1.17% | 27 |
|
|
2020
Q2 | $20.9M | Sell |
227,973
-501
| -0.2% | -$48K | 1.14% | 28 |
|
|
2020
Q1 | $20.6M | Sell |
228,474
-10,890
| -5% | -$1.16M | 1.34% | 22 |
|
|
2019
Q4 | $27.2M | Sell |
239,364
-2,036
| -0.8% | -$223K | 1.37% | 30 |
|
|
2019
Q3 | $26.2M | Sell |
241,400
-5,465
| -2% | -$570K | 1.38% | 26 |
|
|
2019
Q2 | $24M | Sell |
246,865
-6,256
| -2% | -$571K | 1.25% | 30 |
|
|
2019
Q1 | $23.1M | Sell |
253,121
-93,454
| -27% | -$8.36M | 1.24% | 29 |
|
|
2018
Q4 | $31.5M | Buy |
346,575
+14,099
| +4% | +$1.32M | 1.34% | 20 |
|
|
2018
Q3 | $32.7M | Sell |
332,476
-22,575
| -6% | -$2.09M | 1.17% | 27 |
|
|
2018
Q2 | $30.4M | Buy |
355,051
+244
| +0.1% | +$20.4K | 1.16% | 29 |
|
|
2018
Q1 | $28.5M | Buy |
354,807
+4,196
| +1% | +$346K | 1.09% | 34 |
|
|
2017
Q4 | $28.3M | Sell |
350,611
-5,511
| -2% | -$441K | 1.04% | 34 |
|
|
2017
Q3 | $27.7M | Sell |
356,122
-15,497
| -4% | -$1.29M | 1.07% | 34 |
|
|
2017
Q2 | $33M | Sell |
371,619
-17,068
| -4% | -$1.44M | 1.29% | 23 |
|
|
2017
Q1 | $31.3M | Buy |
388,687
+2,350
| +0.6% | +$184K | 1.27% | 21 |
|
|
2016
Q4 | $27.5M | Buy |
386,337
+1,478
| +0.4% | +$116K | 1.2% | 22 |
|
|
2016
Q3 | $33.3M | Sell |
384,859
-23
| -0% | -$2K | 1.53% | 16 |
|
|
2016
Q2 | $33.4M | Buy |
384,882
+7,805
| +2% | +$631K | 1.56% | 15 |
|
|
2016
Q1 | $28.3M | Buy |
377,077
+3,092
| +0.8% | +$233K | 1.41% | 17 |
|
|
2015
Q4 | $28.8M | Buy |
373,985
+13,442
| +4% | +$1.01M | 1.43% | 15 |
|
|
2015
Q3 | $24.1M | Sell |
360,543
-72,610
| -17% | -$5.35M | 1.19% | 25 |
|
|
2015
Q2 | $32.1M | Sell |
433,153
-8,687
| -2% | -$664K | 1.43% | 18 |
|
|
2015
Q1 | $34.5M | Buy |
441,840
+16,414
| +4% | +$1.24M | 1.53% | 17 |
|
|
2014
Q4 | $30.7M | Sell |
425,426
-16,690
| -4% | -$1.16M | 1.37% | 18 |
|
|
2014
Q3 | $27.4M | Buy |
442,116
+27,225
| +7% | +$1.73M | 1.19% | 23 |
|
|
2014
Q2 | $26.5M | Buy |
414,891
+20,760
| +5% | +$1.26M | 1.12% | 24 |
|
|
2014
Q1 | $24.3M | Sell |
394,131
-37,728
| -9% | -$2.2M | 1.09% | 28 |
|
|
2013
Q4 | $24.8M | Buy |
431,859
+4,481
| +1% | +$254K | 0.89% | 28 |
|
|
2013
Q3 | $22.8M | Sell |
427,378
-34,755
| -8% | -$1.87M | 0.89% | 29 |
|
|
2013
Q2 | $23.8M | Buy |
+462,133
| New | +$22.8M | 0.85% | 29 |
|
Other funds holding MDT
Klingenstein Fields & Co's MDT Position: Q2 2024 in Review
Klingenstein Fields & Co sold out of Medtronic (MDT) in Q2 2024, closing a stake of 195,210 shares — an estimated $17M sold.
Klingenstein Fields & Co first reported a position in MDT in Q2 2013 and held it in 44 quarters. The position peaked at $34.5M in Q1 2015. 2,024 funds tracked by Wall St. Rank hold MDT as of Q2 2024.
- Klingenstein Fields & Co reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
- Klingenstein Fields & Co sold 195,210 Medtronic shares in Q2 2024, an estimated $17M.
- Klingenstein Fields & Co first reported a position in Medtronic in Q2 2013 and held it in 44 quarters.
- Klingenstein Fields & Co's Medtronic position peaked at $34.5M in Q1 2015.
- 2,024 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.
Based on Klingenstein Fields & Co's 13F filing for Q2 2024, filed 1 Aug 2024.